One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

Gardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all ...

Researchers have noted the efficiency of single-dose HPV vaccines before. In 2022, a World Health Organization study concluded that girls and women aged 9-20 could follow a one or two-dose ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

There are many cancer-causing types of HPV; types 16 and 18 cause 70 percent of cases of cervical cancer, while types 6 and 11 cause 90 percent of cases of genital warts. The Gardasil® vaccine—called ...

In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization. Merck's human papillomavirus (HPV) vaccine Gardasil should ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.